PH26920A - Medicaments for the treatment of cerebral apoplexy - Google Patents
Medicaments for the treatment of cerebral apoplexy Download PDFInfo
- Publication number
- PH26920A PH26920A PH39203A PH39203A PH26920A PH 26920 A PH26920 A PH 26920A PH 39203 A PH39203 A PH 39203A PH 39203 A PH39203 A PH 39203A PH 26920 A PH26920 A PH 26920A
- Authority
- PH
- Philippines
- Prior art keywords
- active compounds
- use according
- group
- medicaments
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Instructional Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3831888A DE3831888A1 (de) | 1988-09-20 | 1988-09-20 | Arzneimittel zur behandlung von apoplexia cerebri |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH26920A true PH26920A (en) | 1992-12-03 |
Family
ID=6363313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH39203A PH26920A (en) | 1988-09-20 | 1989-09-06 | Medicaments for the treatment of cerebral apoplexy |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US4988700A (fr) |
| EP (1) | EP0360077B1 (fr) |
| JP (1) | JP2669507B2 (fr) |
| KR (2) | KR0135307B1 (fr) |
| AT (1) | ATE91623T1 (fr) |
| AU (1) | AU619895B2 (fr) |
| CA (1) | CA1331139C (fr) |
| DE (2) | DE3831888A1 (fr) |
| DK (1) | DK175128B1 (fr) |
| ES (1) | ES2058426T3 (fr) |
| FI (1) | FI894404L (fr) |
| HU (1) | HU203475B (fr) |
| IE (1) | IE62697B1 (fr) |
| IL (1) | IL91660A (fr) |
| PH (1) | PH26920A (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0564520A1 (fr) * | 1990-12-24 | 1993-10-13 | Merrell Dow Pharmaceuticals Inc. | Utilisation de certains derives de glutarimide dans le traitement de la depression et des etats maniaques |
| DE4135473A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | Triazaspirodecanon-methylchromane |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
| CA2145182C (fr) * | 1992-09-25 | 2001-09-18 | Jonathan A. Bard | Sequences d'adn codant pour des recepteurs alpha 1 adrenergiques humains et leur utilisation |
| WO1994009765A1 (fr) * | 1992-10-23 | 1994-05-11 | New York University | Interactions fonctionnelles entre le s-100b glial et les neurones serotoninergiques du systeme nerveux central |
| AU765142B2 (en) | 1998-06-01 | 2003-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating neurodegenerative disorders |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| JP2002520408A (ja) | 1998-07-17 | 2002-07-09 | シナプティック・ファーマスーティカル・コーポレーション | ヒトα１ｄアドレナリン受容体に特異的な化合物およびその使用 |
| US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| DE19900544A1 (de) * | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
| US20040106623A1 (en) * | 1999-07-16 | 2004-06-03 | Synaptic Pharmaceutical Corporation | Compounds specific for the human alpha1d adrenergic receptor and uses thereof |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| US20040002500A1 (en) * | 2002-06-28 | 2004-01-01 | Fabre Kramer Pharmaceutical, Inc. | Methods for treating attention deficit disorder |
| US20040077996A1 (en) * | 2002-10-22 | 2004-04-22 | Jasperson Keith E. | Drug infusion system with multiple medications |
| ATE489138T1 (de) | 2005-04-13 | 2010-12-15 | Neuraxon Inc | Substituierte indolverbindungen mit nos-hemmender aktivität |
| ZA200809659B (en) * | 2006-04-13 | 2010-03-31 | Neuraxon Inc | 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity |
| WO2009062318A1 (fr) * | 2007-11-16 | 2009-05-22 | Neuraxon, Inc. | Composés d'indole 3,5-substitués ayant une activité d'inhibition de la réabsorption de la nos et de la noradrénaline |
| US20090163451A1 (en) * | 2007-11-16 | 2009-06-25 | Frank Porreca | Methods for treating visceral pain |
| EA201000808A1 (ru) * | 2007-11-16 | 2011-04-29 | Ньюраксон, Инк. | Индольные соединения и способы лечения висцеральной боли |
| KR102357405B1 (ko) | 2021-05-07 | 2022-02-09 | 정진구 | 호흡기 운동기구 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810748D0 (en) * | 1988-05-06 | 1988-06-08 | Beecham Wuelfing Gmbh & Co Kg | Novel treatment |
-
1988
- 1988-09-20 DE DE3831888A patent/DE3831888A1/de not_active Withdrawn
-
1989
- 1989-09-06 PH PH39203A patent/PH26920A/en unknown
- 1989-09-07 DE DE8989116496T patent/DE58904960D1/de not_active Expired - Fee Related
- 1989-09-07 ES ES89116496T patent/ES2058426T3/es not_active Expired - Lifetime
- 1989-09-07 AT AT89116496T patent/ATE91623T1/de not_active IP Right Cessation
- 1989-09-07 EP EP89116496A patent/EP0360077B1/fr not_active Expired - Lifetime
- 1989-09-14 US US07/407,161 patent/US4988700A/en not_active Expired - Lifetime
- 1989-09-15 IL IL91660A patent/IL91660A/xx not_active IP Right Cessation
- 1989-09-15 AU AU41456/89A patent/AU619895B2/en not_active Ceased
- 1989-09-18 FI FI894404A patent/FI894404L/fi not_active Application Discontinuation
- 1989-09-18 CA CA000611736A patent/CA1331139C/fr not_active Expired - Fee Related
- 1989-09-19 IE IE299089A patent/IE62697B1/en not_active IP Right Cessation
- 1989-09-19 KR KR1019890013434A patent/KR0135307B1/ko not_active Expired - Fee Related
- 1989-09-19 DK DK198904616A patent/DK175128B1/da not_active IP Right Cessation
- 1989-09-20 JP JP1242417A patent/JP2669507B2/ja not_active Expired - Fee Related
- 1989-09-20 HU HU894897A patent/HU203475B/hu not_active IP Right Cessation
-
1990
- 1990-09-10 US US07/579,414 patent/US5070102A/en not_active Expired - Lifetime
-
1991
- 1991-06-13 US US07/714,470 patent/US5155128A/en not_active Expired - Lifetime
-
1997
- 1997-11-20 KR KR1019970061360A patent/KR0146486B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU203475B (en) | 1991-08-28 |
| US5155128A (en) | 1992-10-13 |
| FI894404A0 (fi) | 1989-09-18 |
| DK175128B1 (da) | 2004-06-07 |
| IL91660A (en) | 1993-08-18 |
| DE3831888A1 (de) | 1990-03-29 |
| JP2669507B2 (ja) | 1997-10-29 |
| US4988700A (en) | 1991-01-29 |
| FI894404A7 (fi) | 1990-03-21 |
| AU4145689A (en) | 1990-03-29 |
| KR0135307B1 (ko) | 1998-04-23 |
| DK461689D0 (da) | 1989-09-19 |
| IL91660A0 (fr) | 1990-04-29 |
| EP0360077B1 (fr) | 1993-07-21 |
| KR900004352A (ko) | 1990-04-12 |
| ATE91623T1 (de) | 1993-08-15 |
| FI894404L (fi) | 1990-03-21 |
| EP0360077A3 (fr) | 1992-03-11 |
| DK461689A (da) | 1990-03-21 |
| AU619895B2 (en) | 1992-02-06 |
| JPH02121935A (ja) | 1990-05-09 |
| EP0360077A2 (fr) | 1990-03-28 |
| ES2058426T3 (es) | 1994-11-01 |
| HUT52699A (en) | 1990-08-28 |
| IE62697B1 (en) | 1995-02-22 |
| KR0146486B1 (ko) | 1998-08-17 |
| DE58904960D1 (de) | 1993-08-26 |
| CA1331139C (fr) | 1994-08-02 |
| US5070102A (en) | 1991-12-03 |
| IE892990L (en) | 1990-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5070102A (en) | Medicaments for the treatment of cerebral apoplexy | |
| KR100443850B1 (ko) | 헤테로시클릭 화합물의 도파민-ｄ３ 리간드로서의 용도 | |
| JP2002523447A (ja) | ５−ｈｔ６アンタゴニストの使用 | |
| CZ291596A3 (en) | Novel application of serotonin antagonists | |
| JPH11503738A (ja) | 尿失禁を治療するためのα▲下１Ｌ▼アゴニストの使用 | |
| CA2378428C (fr) | Utilisation d'antagonistes de cgrp et d'inhibiteurs de secretion cgrp servant a lutter contre les bouffees de chaleur de la menopause | |
| JPS6197228A (ja) | ジヒドロピリジン類とａｃｅ阻害剤との配合物 | |
| US20170065608A1 (en) | Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome | |
| CA2167004C (fr) | Agent pour le traitement de troubles mentaux associes a des troubles cerebrovasculaires | |
| JPH06509109A (ja) | 選択的トリストミン ｈ３受容体拮抗薬としてのｓ−（３−（４（５））−イミダゾリル）プロピル）イソチオウレア | |
| RU2282446C2 (ru) | Лекарственное средство для хронического суставного ревматизма | |
| US5200410A (en) | Medicaments for the treatment of cerebral apoplexy | |
| JP2618449B2 (ja) | アルコール中毒治療用薬剤 | |
| CA2436083A1 (fr) | Utilisation d'antagonistes doubles h3 et m2 dans le traitement de troubles cognitifs | |
| AU8836598A (en) | Methods for preventing and treating pestivirus infection and associated diseases | |
| CA2440670A1 (fr) | Agent pour le traitement prophylactique ou therapeutique de la cardiopathie ischemique chez les personnes atteintes du diabete | |
| CA1327163C (fr) | Derives de la piperazine a effet anxyolitique | |
| JP2002326934A (ja) | ピロール誘導体を使用するための方法、キット及び組成物 | |
| WO1995028933A1 (fr) | Utilisation de derives arylpiperazines dans le traitement de la maladie de parkinson et de psychoses | |
| CA2357110A1 (fr) | Methode de traitement de la polykystose renale | |
| WO1995003041A1 (fr) | Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues | |
| JPH09500648A (ja) | 置換アザスピランによるヒト免疫不全ウイルス複製の阻害法 | |
| EP0717622A1 (fr) | Procedes de traitement du vih au moyen d'azaspiranes | |
| WO1993014760A2 (fr) | Procedes | |
| NZ222401A (en) | Pharmaceutical compositions which include a calcium antagonist and 7-(n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-(s)-alanyl)-1,4-dithia-7-azaspiro(4,4)nonane-8-(s)-carboxylic acid |